Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Gilbert Harlan Daniels, M.D.

Co-Author

This page shows the publications co-authored by Gilbert Daniels and Lori Wirth.
Connection Strength

0.664
  1. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy. Thyroid. 2021 Oct; 31(10):1451-1462.
    View in: PubMed
    Score: 0.242
  2. Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-Response. Clin Cancer Res. 2015 Dec 15; 21(24):5640-1.
    View in: PubMed
    Score: 0.165
  3. Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib. Clin Cancer Res. 2015 Mar 01; 21(5):1028-35.
    View in: PubMed
    Score: 0.155
  4. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. Cancer Cell. 2018 08 13; 34(2):242-255.e5.
    View in: PubMed
    Score: 0.050
  5. Medullary carcinoma. J Natl Compr Canc Netw. 2010 May; 8(5):512-30.
    View in: PubMed
    Score: 0.028
  6. A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid. 2008 Mar; 18(3):317-23.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.